Ligand-Based Target Prediction with Signature Fingerprints
暂无分享,去创建一个
Ola Spjuth | Lars Carlsson | Jonathan Alvarsson | Jarl E. S. Wikberg | Martin Eklund | Ola Engkvist | Tobias Noeske | O. Spjuth | Tobias Noeske | L. Carlsson | J. Wikberg | O. Engkvist | M. Eklund | Jonathan Alvarsson
[1] Robert D. Carr,et al. The Signature Molecular Descriptor. 4. Canonizing Molecules Using Extended Valence Sequences , 2004, J. Chem. Inf. Model..
[2] D J Rogers,et al. A Computer Program for Classifying Plants. , 1960, Science.
[3] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[4] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[5] Ulf Norinder,et al. QSAR investigation of NaV1.7 active compounds using the SVM/Signature approach and the Bioclipse Modeling platform. , 2013, Bioorganic & medicinal chemistry letters.
[6] Stefan Schmitt,et al. Do structurally similar ligands bind in a similar fashion? , 2006, Journal of medicinal chemistry.
[7] Anthony Nicholls,et al. What do we know and when do we know it? , 2008, J. Comput. Aided Mol. Des..
[8] Sereina Riniker,et al. Open-source platform to benchmark fingerprints for ligand-based virtual screening , 2013, Journal of Cheminformatics.
[9] Donald P. Visco,et al. Computer-aided molecular design using the Signature molecular descriptor: Application to solvent selection , 2010, Comput. Chem. Eng..
[10] Thierry Kogej,et al. Comparison of Molecular Fingerprint Methods on the Basis of Biological Profile Data , 2009, J. Chem. Inf. Model..
[11] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[12] Scott Boyer,et al. Interpretation of Nonlinear QSAR Models Applied to Ames Mutagenicity Data , 2009, J. Chem. Inf. Model..
[13] D. Rogers,et al. Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.
[14] Egon L. Willighagen,et al. The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..
[15] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[16] Robert D. Clark,et al. Managing bias in ROC curves , 2008, J. Comput. Aided Mol. Des..
[17] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies , 2003, J. Chem. Inf. Comput. Sci..
[18] A. Vulpetti,et al. Comparability of Mixed IC50 Data – A Statistical Analysis , 2013, PloS one.
[19] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[20] J. Hintze,et al. Violin plots : A box plot-density trace synergism , 1998 .
[21] J. Ware. The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.
[22] Kathleen F. Kerr,et al. Net reclassification indices for evaluating risk prediction instruments: a critical review. , 2014, Epidemiology.
[23] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[24] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[25] Ola Spjuth,et al. Integrated Decision Support for Assessing Chemical Liabilities , 2011, J. Chem. Inf. Model..
[26] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[27] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[28] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[29] Kathrin Heikamp,et al. Large-Scale Similarity Search Profiling of ChEMBL Compound Data Sets , 2011, J. Chem. Inf. Model..
[30] Scott Boyer,et al. Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling , 2006, J. Chem. Inf. Model..
[31] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[32] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 2. Enumerating Molecules from Their Extended Valence Sequences , 2003, J. Chem. Inf. Comput. Sci..
[33] Kathrin Heikamp,et al. Comparison of Confirmed Inactive and Randomly Selected Compounds as Negative Training Examples in Support Vector Machine-Based Virtual Screening , 2013, J. Chem. Inf. Model..
[34] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[35] C. Steinbeck,et al. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.